BurgueraB, AgustiA, ArnerP, BaltasarA, BarbeF, BarceloA, BretonI, CabanesT, CasanuevaFF, CouceME, DieguezC, FiolM, Fernandez RealJM, FormigueraX, FruhbeckG, Garcia RomeroM, Garcia SanzM, GhigoE, GomisR, HigaK, IbarraO, LacyA, LarradA, MasmiquelL, MoizéV, MorenoB, MoreiroJ, RicartW, RiescoM, SalinasR, SalvadorJ, Pi-SunyerFX, ScopinaroN, SjostromL, PaganA, PeregV, Sánchez PernauteA, TorresA, UrgelesJR, Vidal-PuigA, VidalJ, VilaM. Critical assessment of the current guidelines for the management and treatment of morbidly obese patients. J Endocrinol Invest, 2007; 30: 844–52.
2.
RamosAM, PellandaLC, VieiraPL, RibeiroDP, MentiE, and PortalVL. Prognostic value of fasting glucose levels in elderly patients with acute coronary syndrome. Arquivos Brasileiros de Cardiologia, 2012; 98: 203–10.
3.
JakicicJM, JaramilloSA, BalasubramanyamA, BancroftB, CurtisJM, MathewsA, PereiraM, RegensteinerJG, RibislPM. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study. Look AHEAD Study Group. Int J Obes (Lond), 2009; 33: 305–16.
BrixnerDI, BronM, BellowsBK, YeX, YuJ, RaparlaS, OderdaGM. Evaluation of cardiovascular risk factors, events, and costs across four BMI categories. Obesity (Silver Spring), 2013; 21: 1284–92.
6.
OgdenCL, CarrollMD, KitBK, FlegalKM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010. JAMA, 2012; 307: 483–90.
7.
GuariguataL. Contribute data to the 6th edition of the IDF Diabetes Atlas. Diabetes Res Clin Pract, 2013; 100: 280–81.
8.
BermudezDM, PoriesWJ. New technologies for treating obesity. Minerva Endocrinol, 2013; 38: 165–72.
9.
SchauerPR, KashyapSR, WolskiK, BrethauerSA, KirwanJP, PothierCE, ThomasS, AboodB, NissenSE, BhattDL, MingroneG, PanunziS, De GaetanoA, GuidoneC, IaconelliA, LeccesiL, NanniG, PompA, CastagnetoM, GhirlandaG, and RubinoF. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med, 2012; 366: 1567–85.
10.
PoriesWJ, SwansonMS, MacDonaldKG, LongSB, MorrisPG, BrownBM, BarakatHA, deRamonRA, IsraelG, DolezalJM, et al.Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg, 1995; 222: 339–50; discussion 350–52.
11.
HallTC, PellenMG, SedmanPC, et al.Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg, 2010; 20: 1245–50.
12.
JacobsenSH, OlesenSC, DirksenC, JørgensenNB, Bojsen-MøllerKN, KielgastU, WormD, AlmdalT, NaverLS, HvolrisLE, RehfeldJF, WulffBS, ClausenTR, HansenDL, HolstJJ, MadsbadS. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg, 2012; 22: 1084–96.
13.
DarMS, ChapmanWH3rd, PenderJR, DrakeAJ3rd, O'BrienK, TanenbergRJ, DohmGL, PoriesWJ. GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)?. Obes Surg, 2012; 22: 1077–83.
14.
FlorezH, PanQ, AckermannRT, MarreroDG, Barrett-ConnorE, DelahantyL, KriskaA, SaudekCD, GoldbergRB, RubinRR. Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial. Diabetes Prevention Program Research Group. J Gen Intern Med, 2012; 27: 1594–601.
